• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Windtree Therapeutics Inc (NQ: WINT )

    3.210 -0.080 (-2.43%)
    Streaming Delayed Price Updated: 3:21 PM EDT, Jun 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,250
    Open 3.220
    Bid (Size) 3.100 (1)
    Ask (Size) 3.300 (1)
    Prev. Close 3.290
    Today's Range 3.206 - 3.250
    52wk Range 0.2654 - 6.110
    Shares Outstanding 5,148,219
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news! 
    Via InvestorPlace
    (WINT) - Analyzing Windtree Therapeutics's Short Interest
    Via Benzinga

    Performance

    YTD
    +359.82%
    +359.82%
    1 Month
    -11.81%
    -11.81%
    3 Month
    +777.05%
    +777.05%
    6 Month
    +346.45%
    +346.45%
    1 Year
    +143.18%
    +143.18%

    More News

    Read More
    Why Windtree Therapeutics (WINT) Stock Is Getting Hammered
    Via Benzinga
    Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    WINT Stock Earnings: Windtree Therapeutics Beats EPS for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
    Via Benzinga
    Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
    Via Benzinga
    Week in Review: Lee’s Pharma Signs $138 Million Agreement For China Rights To Heart Failure Therapy
    Via Talk Markets
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
    Via ACCESSWIRE
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
    Via Benzinga
    Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected Mid-2024
    Via ACCESSWIRE
    Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024
    Via Benzinga
    Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Windtree Therapeutics (NASDAQ:WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
    Via ACCESSWIRE
    Stocks That Hit 52-Week Lows On Thursday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.